Work

Is there a benefit of re-induction therapy in adult patients with AML with <20% blasts?

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.7021

Authors: Kavya Kannamma Kannan, Paz Vellanki, Scott Isom, Bernard Tawfik, Allison Marie Winter, Heidi D. Klepin, Leslie R. Ellis, Rupali Roy Bhave, Dianna Howard, Megan Manuel, Sarah Dralle, Susan Lyerly, Bayard L. Powell, Timothy S. Pardee

Institutions: Wake Forest University Health Sciences, Wake Forest University, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Atrium Health Wake Forest Baptist, Wake Forest Baptist Comprehensive Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891848708

Cites:

Cited by:

Related to: 10